These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 34957088)

  • 1. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer.
    Bi C; Xiao G; Liu C; Yan J; Chen J; Si W; Zhang J; Liu Z
    Front Cell Dev Biol; 2021; 9():702414. PubMed ID: 34957088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
    Sun X; Pan CQ; Xing H
    Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective.
    Wang L; Cao ZM; Zhang LL; Li JM; Lv WL
    Front Immunol; 2022; 13():923599. PubMed ID: 35911738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
    Zha C; Peng Z; Huang K; Tang K; Wang Q; Zhu L; Che B; Li W; Xu S; Huang T; Yu Y; Zhang W
    Front Oncol; 2023; 13():1196217. PubMed ID: 37265797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease.
    Ni Y; Ni L; Zhuge F; Fu Z
    Mol Nutr Food Res; 2020 Sep; 64(17):e2000375. PubMed ID: 32738185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.
    Arab JP; Arrese M; Shah VH
    Hepatol Res; 2020 Apr; 50(4):407-418. PubMed ID: 31840358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites.
    Lu D; Zou X; Zhang H
    Front Cardiovasc Med; 2022; 9():948755. PubMed ID: 35845042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
    Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
    J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut-liver axis in fatty liver disease: role played by natural products.
    Ming Z; Ruishi X; Linyi X; Yonggang Y; Haoming L; Xintian L
    Front Pharmacol; 2024; 15():1365294. PubMed ID: 38686320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-Microbiota Interactions in Liver Inflammation and Cancer.
    Giraud J; Saleh M
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq S; Stärkel P; Delzenne NM; de Timary P
    Alcohol; 2019 Feb; 74():105-111. PubMed ID: 30031625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota mediated molecular events and therapy in liver diseases.
    Qi X; Yang M; Stenberg J; Dey R; Fogwe L; Alam MS; Kimchi ET; Staveley-O'Carroll KF; Li G
    World J Gastroenterol; 2020 Dec; 26(48):7603-7618. PubMed ID: 33505139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.